News
Ashfield Engage bolsters patient solutions offering in Canada with Medaxis acquisition
Ashfield Engage, part of UDG Healthcare, has announced the acquisition of Medaxis, a patient engagement services partner for the life sciences industry, providing services to healthcare professionals and patients.
Ashfield Engage, which has a Patient Solutions offering specializing in patient...
News
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical
Fermenta Biotech Limited announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy’s Laboratories Limited (DRL). In this arrangement, FBL will exclusively license its proprietary biocatalytic technology for synthesis...
News
Genezen appoints Senior Director of Business Development to support rapid growth
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing services, has appointed Laura Jacanin as Senior Director of Business Development.
Previously with similar roles at Wuxi,...
News
19th Edition of BioAsia to focus on Future Readiness of the Life-Sciences Industry; 2-Day event to kick-start on February 24th
19th edition of the Asia’s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Government of Telangana will be held during February 24th and 25th, 2022 in a virtual format. The theme of this year’s edition...
News
Vetter’s Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner featured on the “Molecule to Market” podcast
Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of the “Molecule to Market” podcast to share his personal background, the history of Vetter, and...
News
Indian Pharmaceutical Industry Now And In The Days To Come
It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater to more than 50% of world vaccination supplies as well as 40% generic demand in...
News
Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina
Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Jim Kennamer as Senior Vice President and Site Head of North Carolina.
With over 30 years’...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.